Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recovery of organ-specific tissue oxygen delivery at restrictive transfusion thresholds after fluid treatment in ovine haemorrhagic shock.
Dyer WB, Simonova G, Chiaretti S, Bouquet M, Wellburn R, Heinsar S, Ainola C, Wildi K, Sato K, Livingstone S, Suen JY, Irving DO, Tung JP, Li Bassi G, Fraser JF. Dyer WB, et al. Among authors: chiaretti s. Intensive Care Med Exp. 2022 Apr 4;10(1):12. doi: 10.1186/s40635-022-00439-6. Intensive Care Med Exp. 2022. PMID: 35377109 Free PMC article.
An Ovine Model of Hemorrhagic Shock and Resuscitation, to Assess Recovery of Tissue Oxygen Delivery and Oxygen Debt, and Inform Patient Blood Management.
Dyer WB, Tung JP, Li Bassi G, Wildi K, Jung JS, Colombo SM, Rozencwajg S, Simonova G, Chiaretti S, Temple FT, Ainola C, Shuker T, Palmieri C, Shander A, Suen JY, Irving DO, Fraser JF. Dyer WB, et al. Among authors: chiaretti s. Shock. 2021 Dec 1;56(6):1080-1091. doi: 10.1097/SHK.0000000000001805. Shock. 2021. PMID: 34014886
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab.
Jabbour EJ, Kantarjian HM, Goekbuget N, Shah BD, Chiaretti S, Park JH, Rijneveld AW, Gore L, Fleming S, Logan AC, Ribera JM, Menne TF, Mezzi K, Zaman F, Velasco K, Boissel N. Jabbour EJ, et al. Among authors: chiaretti s. Blood Cancer J. 2024 Nov 19;14(1):203. doi: 10.1038/s41408-024-01179-4. Blood Cancer J. 2024. PMID: 39562780 Free PMC article. Review.
CD146 Molecule Expression in B Cells Acute Lymphoblastic Leukemia (B-ALLs): A Flow-Cytometric Marker for an Accurate Diagnostic Workup.
Laganà A, Totaro M, Bisegna ML, Elia L, Intoppa S, Beldinanzi M, Matarazzo M, di Trani M, Costa A, Maglione R, Mandelli B, Chiaretti S, Martelli M, De Propris MS. Laganà A, et al. Among authors: chiaretti s. Mediterr J Hematol Infect Dis. 2024 Sep 1;16(1):e2024064. doi: 10.4084/MJHID.2024.064. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 39258185 Free PMC article.
How I treat adult Ph-positive ALL.
Chiaretti S, Foà R. Chiaretti S, et al. Blood. 2024 Aug 20:blood.2023023152. doi: 10.1182/blood.2023023152. Online ahead of print. Blood. 2024. PMID: 39172753
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Lazzarotto D, Cerrano M, Papayannidis C, Chiaretti S, Mosna F, Fracchiolla N, Zappasodi P, Imbergamo S, Del Principe MI, Lunghi M, Lussana F, Piccini M, Fumagalli M, Dargenio M, Salutari P, Forghieri F, Da Molin TG, Bonifacio M, Olivi M, Giglio F, Trappolini S, Leoncin M, Mule A, Delia M, Pasciolla C, Grimaldi F, Cambo B, Santoro L, Guolo F, Minetto P, Defina M, Chiusolo P, Fanin M, Mauro E, Aprile L, Mazzone C, Trastulli F, Ciccone M, De Gobbi M, Cignetti A, De Bellis E, Mancini V, Piciocchi A, Vignetti M, Marsili G, Starza ID, Fanin R, Luppi M, Ferrara F, Pizzolo G, Bassan R, Foa R, Candoni A. Lazzarotto D, et al. Among authors: chiaretti s. Haematologica. 2024 Aug 15. doi: 10.3324/haematol.2024.285638. Online ahead of print. Haematologica. 2024. PMID: 39157875 Free article.
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study.
Kaiser F, Lunghi M, Cardinali D, Bellomarino V, Beldinanzi M, Starza ID, Malfona F, Basilico CM, Defina M, Mastaglio S, Giglio F, Lazzarotto D, Salutari P, Piccini M, Cardinali V, Pierini A, Fracchiolla NS, Di Biase F, Annunziata M, Di Trani M, Foa R, Chiaretti S. Kaiser F, et al. Among authors: chiaretti s. Haematologica. 2024 Dec 1;109(12):4095-4099. doi: 10.3324/haematol.2024.285258. Haematologica. 2024. PMID: 39086308 Free PMC article. No abstract available.
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients.
Hovorkova L, Winkowska L, Skorepova J, Krumbholz M, Benesova A, Polivkova V, Alten J, Bardini M, Meyer C, Kim R, Trahair TN, Clappier E, Chiaretti S, Henderson M, Sutton R, Sramkova L, Stary J, Polakova KM, Marschalek R, Metzler M, Cazzaniga G, Cario G, Trka J, Zaliova M, Zuna J. Hovorkova L, et al. Among authors: chiaretti s. Mol Cancer. 2024 Jul 5;23(1):138. doi: 10.1186/s12943-024-02053-4. Mol Cancer. 2024. PMID: 38970095 Free PMC article.
179 results